Eagle Pharmaceuticals Inc

Great News! Now you can buy fractional shares of Eagle Pharmaceuticals Inc

What is Fractional Shares?

Fractional shares are pieces of one full share of a company or exchange-traded fund (ETF).

In INDmoney, you can buy Eagle Pharmaceuticals Inc stock in any dollar amount, or any other stock you want.

$10

$50

$100

EGRX

Eagle Pharmaceuticals Inc (EGRX)

Q: What is Eagle Pharmaceuticals Inc (EGRX) share price today?

Eagle Pharmaceuticals Inc (EGRX) share price today is $45.26

Q: Can Indians buy Eagle Pharmaceuticals Inc (EGRX) shares?

Yes, Indians can buy Eagle Pharmaceuticals Inc (EGRX) shares. As per RBI rule, an Indian citizen can invest 250,000 dollars a year in foreign markets.

Q: How can I buy Eagle Pharmaceuticals Inc (EGRX) shares from India?

Three ways to invest in Eagle Pharmaceuticals Inc (EGRX) stocks from India are 1.Investment through apps: INDmoney is one of the leading apps that help you invest in Eagle Pharmaceuticals Inc (EGRX) stocks from India 2.Investment through Indian brokers tied up with a foreign broker 3.Investment by opening an account with a Foreign broker

Q: Can Fractional shares of Eagle Pharmaceuticals Inc (EGRX) be purchased?

You can buy just a fraction of Eagle Pharmaceuticals Inc (EGRX) shares.

Q: What are the documents required to start investing in Eagle Pharmaceuticals Inc (EGRX) stocks?

You will need a proof of Identification (PAN, Aadhaar etc) and proof of address (Aadhaar, Voter ID etc) to invest in Eagle Pharmaceuticals Inc (EGRX) stocks . The entire process is paperless and can be completed seamlessly.

$45.264.82%▲

Key Stats

Open	$46.08
Today Low/High	$45 / $46.73
52 Week Low/High	$36.48 / $58.25
Market Cap	$603.85M

Company Details

Eagle Pharmaceuticals Inc. is a fully integrated pharmaceutical company with research and development, clinical, manufacturing and commercial expertise. Eagle is committed to developing innovative medicines that result in meaningful improvements in patients' lives. Eagle's commercialized products include RYANODEX®, BENDEKA®, BELRAPZO®, and its oncology and CNS/metabolic critical care pipeline includes product candidates with the potential to address underserved therapeutic areas across multiple disease states.